Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1

Status

Completed 3Recruiting 2Unknown 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 2Plasma cell 1

Conditions

Paraproteinemias 1Nervous System Diseases 1Neoplasms, Plasma Cell 1Myasthenia Gravis 1Multiple Myeloma 1Kidney Diseases 1Hematologic Diseases 1Autoimmune Diseases 1Acute Kidney Injury 1

Interventions

Cyclophosphamide 1495Cisplatin 1431Paclitaxel 1339Radiotherapy 1308Carboplatin 1264Gemcitabine 1225Docetaxel 1134Bevacizumab 1068Fluorouracil 906Doxorubicin 799Dexamethasone 753Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 693Etoposide 674Irinotecan 639Filgrastim 624Nivolumab 585Cytarabine 585Leucovorin 582Vincristine 512Cetuximab 478Prednisone 477Bortezomib 472Trastuzumab 469Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 443Lenalidomide 434

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Plasma Exchange × Clear all
NCT07532707 2026-04-16

Efficacy of IVIG Versus PLEX in Myasthenic Crisis in Syria.

Damascus University

Phase NA Completed
50 enrolled

Myasthenia Gravis

NCT00120263 2025-03-25

Trial of Plasma Exchange for Acute Renal Failure at the Onset of Myeloma

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase NA Completed
92 enrolled
GenitourinaryPlasma cell

Multiple Myeloma, Neoplasms, Plasma Cell, Acute Kidney Injury

NCT01210716 2013-09-23

Evaluation of Therapeutic Plasma Exchange (TPE) Procedure Using the AMICUS Device

Fenwal, Inc.

Phase 3 Completed
37 enrolled 7 charts
Genitourinary

Autoimmune Diseases, Hematologic Diseases, Kidney Diseases, Nervous System Diseases, Paraproteinemias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡